The Oncosearch | Oncotarget

Oral 4-(N)-stearoyl gemcitabine nanoparticles inhibit tumor growth in mouse models Research Paper

Caixia Wang, Yuanqiang Zheng, Michael A. Sandoval, Solange A. Valdes, Zhe Chen, Dharmika S. Lansakara-P, Maolin Du, Yanchun Shi, Zhengrong Cui

Published Sep 23, 2017 · Vol. 8, No. 52 · pp. 89876-89886

ING4 expressing oncolytic vaccinia virus promotes anti-tumor efficiency and synergizes with gemcitabine in pancreatic cancer Research Paper

Yinfang Wu, Xiaozhou Mou, Shibing Wang, Xing-E Liu, Xiaodong Sun

Published Sep 20, 2017 · Vol. 8, No. 47 · pp. 82728-82739

Adjuvant chemotherapy for muscle-invasive bladder cancer: a systematic review and network meta-analysis of randomized clinical trials Meta-Analysis

Hyung Suk Kim, Chang Wook Jeong, Cheol Kwak, Hyeon Hoe Kim, Ja Hyeon Ku

Published Sep 18, 2017 · Vol. 8, No. 46 · pp. 81204-81214

Targeting the HGF/c-MET pathway: stromal remodelling in pancreatic cancer Research Paper

Srinivasa P. Pothula, Zhihong Xu, David Goldstein, Neil Merrett, Romano C. Pirola, Jeremy S. Wilson, Minoti V. Apte

Published Sep 11, 2017 · Vol. 8, No. 44 · pp. 76722-76739

The combination of temozolomide-irinotecan regresses a doxorubicin-resistant patient-derived orthotopic xenograft (PDOX) nude-mouse model of recurrent Ewingâ€™s sarcoma with a FUS-ERG fusion and CDKN2A deletion: Direction for third-line patient therapy Research Paper

Kentaro Miyake, Takashi Murakami, Tasuku Kiyuna, Kentaro Igarashi, Kei Kawaguchi, Masuyo Miyake, Yunfeng Li, Scott D. Nelson, Sarah M. Dry, Michael Bouvet, Irmina A. Elliott, Tara A. Russell, Arun S. Singh, Mark A. Eckardt, Yukihiko Hiroshima, Masashi Momiyama, Ryusei Matsuyama, Takashi Chishima, Itaru Endo, Fritz C. Eilber, Robert M. Hoffman

Published Sep 8, 2017 · Vol. 8, No. 61 · pp. 103129-103136

B7-H3 combats apoptosis induced by chemotherapy by delivering signals to pancreatic cancer cells Research Paper

Dongbao Li, Jun Wang, Jian Zhou, Shenghua Zhan, Yang Huang, Fei Wang, Zixiang Zhang, Dongming Zhu, Hua Zhao, Dechun Li, Gang Chen, Xinguo Zhu, Xin Zhao

Published Aug 24, 2017 · Vol. 8, No. 43 · pp. 74856-74868

The efficacy and safety of different pharmacological interventions for patients with advanced biliary tract cancer: A network meta-analysis Meta-Analysis

Xin-Fang Sun, Zhi-Kuan He, Jin-Ping Sun, Quan-Xing Ge, Er-Dong Shen

Published Aug 24, 2017 · Vol. 8, No. 59 · pp. 100657-100667

Phosphorylated heat shock protein 27 as a potential biomarker to predict the role of chemotherapy-induced autophagy in osteosarcoma response to therapy Research Paper

Janice M. Santiago-Oâ€™Farrill, Eugenie S. Kleinerman, Mario G. Hollomon, Andrew Livingston, Wei-Lien Wang, Jen-Wei Tsai, Nancy B. Gordon

Published Aug 17, 2017 · Vol. 9, No. 2 · pp. 1602-1616

SWI/SNF aberrations sensitize pancreatic cancer cells to DNA crosslinking agents Research Paper

Jean Davidson, Zhewei Shen, Xue Gong, Jonathan R. Pollack

Published Aug 8, 2017 · Vol. 9, No. 11 · pp. 9608-9617

Outcomes of phase I clinical trials for patients with advanced pancreatic cancer: update of the MD Anderson Cancer Center experience Research Paper

Jennifer B. Goldstein, Chad Tang, Kenneth R. Hess, David Hong, Vivek Subbiah, Filip Janku, Siqing Fu, Daniel D. Karp, Aung Naing, Apostolia Maria Tsimberidou, Jennifer Wheler, Ralph Zinner, Milind Javle, Gauri R. Varadhachary, Robert A. Wolff, David R. Fogelman, Funda Meric-Bernstam, Sarina A. Piha-Paul

Published Aug 3, 2017 · Vol. 8, No. 50 · pp. 87163-87173

Cell cycle specific radiosensitisation by the disulfiram and copper complex Research Paper

Mathias Tesson, Giorgio Anselmi, Caitlin Bell, Robert Mairs

Published Jul 25, 2017 · Vol. 8, No. 39 · pp. 65900-65916

Suppression of pancreatic adenocarcinoma upregulated factor (PAUF) increases the sensitivity of pancreatic cancer to gemcitabine and 5FU, and inhibits the formation of pancreatic cancer stem like cells Research Paper

Jae Hee Cho, Sun A. Kim, Soo Been Park, Hee Man Kim, Si Young Song

Published Jul 22, 2017 · Vol. 8, No. 44 · pp. 76398-76407

lncRNA MALAT1, HOTTIP and PVT1 as predictors for predicting the efficacy of GEM based chemotherapy in first-line treatment of pancreatic cancer patients Research Paper

Cui-Juan Wang, Sheng-Bin Shi, Jing Tian, Jun Xu, Zuo-Xing Niu

Published Jul 18, 2017 · Vol. 8, No. 56 · pp. 95108-95115

Optimal adjuvant chemotherapy for resected pancreatic adenocarcinoma: a systematic review and network meta-analysis Clinical Research Papers

Jian-Bo Xu, Bin Jiang, Ya Chen, Fu-Zhen Qi, Jian-Huai Zhang, Hang Yuan

Published Jul 7, 2017 · Vol. 8, No. 46 · pp. 81419-81429

DCK expression, a potential predictive biomarker in the adjuvant gemcitabine chemotherapy for biliary tract cancer after surgical resection: results from a phase II study Clinical Research Papers

Sang Myung Woo, Kyong-Ah Yoon, Eun Kyung Hong, Weon Seo Park, Sung-Sik Han, Sang-Jae Park, Jungnam Joo, Eun Young Park, Ju Hee Lee, Yun-Hee Kim, Tae Hyun Kim, Woo Jin Lee

Published Jul 6, 2017 · Vol. 8, No. 46 · pp. 81394-81404

Antitumor activity of gemcitabine against high-grade meningioma in vitro and in vivo Research Paper

Hiroyuki Takeda, Masashi Okada, Kenta Kuramoto, Shuhei Suzuki, Hirotsugu Sakaki, Tomomi Sanomachi, Shizuka Seino, Takashi Yoshioka, Hirofumi Hirano, Kazunori Arita, Chifumi Kitanaka

Published Jun 29, 2017 · Vol. 8, No. 53 · pp. 90996-91008

Preclinical efficacy of the novel competitive NAMPT inhibitor STF-118804 in pancreatic cancer Research Paper

Jair Machado Espindola-Netto, Claudia C.S. Chini, Mariana TarragÃ³, Enfeng Wang, Shamit Dutta, Krishnendu Pal, Debabrata Mukhopadhyay, Mauro Sola-Penna, Eduardo N. Chini

Published Jun 29, 2017 · Vol. 8, No. 49 · pp. 85054-85067

Use of a genome-wide haploid genetic screen to identify treatment predicting factors: a proof-of-principle study in pancreatic cancer Research Paper

Yuk Ting Ma, Sarah M. Leonard, Naheema Gordon, Jennifer Anderton, Claire James, David Huen, Ciaran B. Woodman, Daniel H. Palmer

Published Jun 29, 2017 · Vol. 8, No. 38 · pp. 63635-63645

Cell cycle perturbation induced by gemcitabine in human tumor cells in cell culture, xenografts and bladder cancer patients: implications for clinical trial designs combining gemcitabine with a Chk1 inhibitor Research Paper

Ryan Montano, Nadeem Khan, Huagang Hou, John Seigne, Marc S. Ernstoff, Lionel D. Lewis, Alan Eastman

Published Jun 28, 2017 · Vol. 8, No. 40 · pp. 67754-67768

Inhibition of CHK1 sensitizes Ewing sarcoma cells to the ribonucleotide reductase inhibitor gemcitabine Research Paper

Kelli L. Goss, Stacia L. Koppenhafer, Kathryn M. Harmoney, William W. Terry, David J. Gordon

Published Jun 28, 2017 · Vol. 8, No. 50 · pp. 87016-87032

Publication Alerts

European Cancer and Oncology Congress

Post-Publication Promotion

Search Oncotarget

Oral 4-(N)-stearoyl gemcitabine nanoparticles inhibit tumor growth in mouse models Research Paper

ING4 expressing oncolytic vaccinia virus promotes anti-tumor efficiency and synergizes with gemcitabine in pancreatic cancer Research Paper

Adjuvant chemotherapy for muscle-invasive bladder cancer: a systematic review and network meta-analysis of randomized clinical trials Meta-Analysis

Targeting the HGF/c-MET pathway: stromal remodelling in pancreatic cancer Research Paper

The combination of temozolomide-irinotecan regresses a doxorubicin-resistant patient-derived orthotopic xenograft (PDOX) nude-mouse model of recurrent Ewingâ€™s sarcoma with a FUS-ERG fusion and CDKN2A deletion: Direction for third-line patient therapy Research Paper

B7-H3 combats apoptosis induced by chemotherapy by delivering signals to pancreatic cancer cells Research Paper

The efficacy and safety of different pharmacological interventions for patients with advanced biliary tract cancer: A network meta-analysis Meta-Analysis

Phosphorylated heat shock protein 27 as a potential biomarker to predict the role of chemotherapy-induced autophagy in osteosarcoma response to therapy Research Paper

SWI/SNF aberrations sensitize pancreatic cancer cells to DNA crosslinking agents Research Paper

Outcomes of phase I clinical trials for patients with advanced pancreatic cancer: update of the MD Anderson Cancer Center experience Research Paper

Cell cycle specific radiosensitisation by the disulfiram and copper complex Research Paper

Suppression of pancreatic adenocarcinoma upregulated factor (PAUF) increases the sensitivity of pancreatic cancer to gemcitabine and 5FU, and inhibits the formation of pancreatic cancer stem like cells Research Paper

lncRNA MALAT1, HOTTIP and PVT1 as predictors for predicting the efficacy of GEM based chemotherapy in first-line treatment of pancreatic cancer patients Research Paper

Optimal adjuvant chemotherapy for resected pancreatic adenocarcinoma: a systematic review and network meta-analysis Clinical Research Papers

DCK expression, a potential predictive biomarker in the adjuvant gemcitabine chemotherapy for biliary tract cancer after surgical resection: results from a phase II study Clinical Research Papers

Antitumor activity of gemcitabine against high-grade meningioma in vitro and in vivo Research Paper

Preclinical efficacy of the novel competitive NAMPT inhibitor STF-118804 in pancreatic cancer Research Paper

Use of a genome-wide haploid genetic screen to identify treatment predicting factors: a proof-of-principle study in pancreatic cancer Research Paper

Cell cycle perturbation induced by gemcitabine in human tumor cells in cell culture, xenografts and bladder cancer patients: implications for clinical trial designs combining gemcitabine with a Chk1 inhibitor Research Paper

Inhibition of CHK1 sensitizes Ewing sarcoma cells to the ribonucleotide reductase inhibitor gemcitabine Research Paper

Publication Alerts

European Cancer and Oncology Congress

Oncoscience

Post-Publication Promotion

Search Oncotarget

Oral 4-(N)-stearoyl gemcitabine nanoparticles inhibit tumor growth in mouse models Research Paper

ING4 expressing oncolytic vaccinia virus promotes anti-tumor efficiency and synergizes with gemcitabine in pancreatic cancer Research Paper

Adjuvant chemotherapy for muscle-invasive bladder cancer: a systematic review and network meta-analysis of randomized clinical trials Meta-Analysis

Targeting the HGF/c-MET pathway: stromal remodelling in pancreatic cancer Research Paper

The combination of temozolomide-irinotecan regresses a doxorubicin-resistant patient-derived orthotopic xenograft (PDOX) nude-mouse model of recurrent Ewingâ€™s sarcoma with a FUS-ERG fusion and CDKN2A deletion: Direction for third-line patient therapy Research Paper

B7-H3 combats apoptosis induced by chemotherapy by delivering signals to pancreatic cancer cells Research Paper

The efficacy and safety of different pharmacological interventions for patients with advanced biliary tract cancer: A network meta-analysis Meta-Analysis

Phosphorylated heat shock protein 27 as a potential biomarker to predict the role of chemotherapy-induced autophagy in osteosarcoma response to therapy Research Paper

SWI/SNF aberrations sensitize pancreatic cancer cells to DNA crosslinking agents Research Paper

Outcomes of phase I clinical trials for patients with advanced pancreatic cancer: update of the MD Anderson Cancer Center experience Research Paper

Cell cycle specific radiosensitisation by the disulfiram and copper complex Research Paper

Suppression of pancreatic adenocarcinoma upregulated factor (PAUF) increases the sensitivity of pancreatic cancer to gemcitabine and 5FU, and inhibits the formation of pancreatic cancer stem like cells Research Paper

lncRNA MALAT1, HOTTIP and PVT1 as predictors for predicting the efficacy of GEM based chemotherapy in first-line treatment of pancreatic cancer patients Research Paper

Optimal adjuvant chemotherapy for resected pancreatic adenocarcinoma: a systematic review and network meta-analysis Clinical Research Papers

DCK expression, a potential predictive biomarker in the adjuvant gemcitabine chemotherapy for biliary tract cancer after surgical resection: results from a phase II study Clinical Research Papers

Antitumor activity of gemcitabine against high-grade meningioma in vitro and in vivo Research Paper

Preclinical efficacy of the novel competitive NAMPT inhibitor STF-118804 in pancreatic cancer Research Paper

Use of a genome-wide haploid genetic screen to identify treatment predicting factors: a proof-of-principle study in pancreatic cancer Research Paper

Cell cycle perturbation induced by gemcitabine in human tumor cells in cell culture, xenografts and bladder cancer patients: implications for clinical trial designs combining gemcitabine with a Chk1 inhibitor Research Paper

Inhibition of CHK1 sensitizes Ewing sarcoma cells to the ribonucleotide reductase inhibitor gemcitabine Research Paper